Newborn screening for congenital hypothyroidism

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 11, 2006, Pages 1291-1298

  Büyükgebiz, Atilla ^a  

^a ACIBADEM HOSPITAL   (Turkey)

Author keywords

Congenital hypothyroidism; Iodine deficiency; Neonatal screening

Indexed keywords

IODINATED POPPYSEED OIL; LIOTHYRONINE; SODIUM CHLORIDE; THYROID HORMONE; THYROTROPIN; THYROXINE;

BREAD; CENTRAL NERVOUS SYSTEM; CONGENITAL HYPOTHYROIDISM; DELAYED DIAGNOSIS; DISEASE SEVERITY; FALSE POSITIVE RESULT; HUMAN; IODINE DEFICIENCY; LOW BIRTH WEIGHT; MENTAL DEFICIENCY; NEWBORN; NEWBORN SCREENING; PREMATURITY; PUERPERIUM; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; TABLET; THYROID FUNCTION; THYROID HORMONE SYNTHESIS;

EID: 33845709588     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.11.1291     Document Type: Review

References (65)

1. Buyukgebiz A. Congenital hypothyroidism clinical aspects and late consequences. Pediatr Endocrinol Rev 2003; 1 (Suppl 2): 185-190.
2. Simsek E, Karabay M, Safak A, Kocabay K. Congenital hypothyroidism and iodine status in Turkey: a comparison between the data obtained from an epidemiological study in school aged children and neonatal screening for congenital hypothyroidism in Turkey. Pediatr Endocrinol Rev 2003; 1 (Suppl 2): 155-161.
3. Yordam N, Ozon A. Neonatal thyroid screening: methods, efficiency, failure. Pediatr Endocrinol Rev 2003; 1 (Suppl 2): 177-184.
4. Jacobsen BB, Brandt NJ. Congenital hypothyroidism in Denmark: incidence, types of thyroid disorders and age at onset of therapy in children. Arch Dis Child 1981; 56: 134-136.
5. Tarim OF, Yordam N. Congenital hypothyroidism in Turkey: a retrospective evaluation of 1000 cases. Turk J Pediatr 1992; 34: 197-202.
6. Dussault JH. The anecdotal history of screening for congenital hypothyroidism. J Clin Endocrinol Metab 1999; 84: 4332-4334.
7. Dussault JH, Laberge C. [Thyroxine (T4) determination in dried blood by radioimmunoassy: a screening method for neonatal hypothyroidism?] Union Med Can 1973; 102: 2062-2064.
8. Dussault JH, Coulombe P, Laberge C, Letarte J, Guyda H, Khoury K. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr 1975; 86: 670-674.
9. Walfish PG. Evaluation of three thyroid function screening tests for detecting neonatal hypothyroidism. Lancet 1976; i: 1208-1210.
10. Recommendations for screening programs for congenital hypothyroidism: Newborn Committee of the American Thyroid Association. Can Med Assoc J 1977; 116: 631-632.
11. Fisher DA, Dussault JH, Foley TP Jr, Klein AH, LeFranchi S, Larsen PR, Mitchell ML, Murphey MH, Walfish PG. Screening for congenital hypothyroidism: results of screening one million North American infants. J Pediatr 1979; 94: 700-705.
12. Illig R, Torresani T, Sobradillo B. Early detection of neonatal hypothyroidism by serial TSH determination in dried blood. Six months experience with a reliable, efficient and inexpensive method. Helv Paediatr Acta 1977; 32: 289-297.
13. Dussault JH, Morisette H. Higher sensitivity of primary thyrotropin in screening for congenital hypothyroidism: A myth? J Clin Endocrinol Metab 1983; 56: 849-852.
14. LeFranchi SH, Hana CE, Krainz PL, Skeels MR, Miyahira RS, Sesser DE. Screening for congenital hypothyroidism with specimen collection in two time periods: results of the Northwest regional screening program. Pediatrics 1985; 76: 734-740.
15. Fisher DA. Second International Conference on Neonatal Thyroid Screening: progress report. J Pediatr 1983; 102: 653-654.
16. Foley TP Jr, Klein AH, Agustin AV. Adaptation of TSH filter paper method for regionalized screening for congenital hypothyroidism. J Lab Clin Med 1977; 90: 11-17.
17. Travis JC, Dungy CI, Huxtable RF, Valenta LJ. Methods of quality control and clinical evaluation of a commercial thyroxine and thyrotropin assay for use in neonates. Clin Chem 1979; 25: 735-740.
18. Miyai K, Ishibashi K, Kawashima M. Enzyme immunoassay of thyroxine in serum and dried blood samples on filter paper. Endocrinol Jpn 1980; 27: 375-380.
19. Torresani TE, Scherz R. Thyroid screening of neonates without use of radioactivity: evaluation of time resolved fluoroimmunoassay of thyrotropin. Clin Chem 1986; 32: 1013-1016.
20. Tuuminen T, Kapyaho KI, Rakkolainen AE, Bugrova VB, Tsukerman GL, Jesse E, Sander J. New neonatal thyrotropin enzyme immunoassay with fluorimetric detection: comparison with time resolved fluoroimmunoassay. Eur J Clin Chem Biochem 1993; 31: 49-53.
21. John R, Henley R, Oversby N. Two years experience with an enhanced chemiluminescent assay for neonatal blood spot TSH. Ann Clin Biochem 1997; 34: 396-399.
22. Walfish PG, Ginsberg J, Rosenberg RA, Howard NJ. Results of a regional cord blood screening programme for detecting neonatal hypothyroidism. Arch Dis Child 1979; 54: 171-177.
23. Brown RS. The thyroid gland. In: Brook CGD, Hindmarsh C, eds. Clinical Pediatric Endocrinology, 4th Ed. Oxford: Blackwell Science, 2001; 288-320.
24. Delange F. Neonatal screening for congenital hypothyroidism: results and perspectives. Horm Res 1997; 48: 51-56.
25. Verkerk PH, Buitendijk SE, Verloove-Vanhorick SP. Congenital hypothyroidism screening and the cutoff for thyrotropin measurement: recommendations from The Netherlands. Am J Public Health 1993; 83: 868-871.
26. Working Group on Neonatal Screening of the European Society for Pediatric Endocrinology. Revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. Horm Res 1999; 52: 49-52.
27. Fisher DA. Effectiveness of newborn screening programs for congenital hypothyroidism: prevelance of missed cases. Pediatr Clin North Am 1987; 34: 881-890.
28. Holtzman C, Yamada Y, Nohara Y, Konishi J, Kasagi K, Endo K, Kojima H, Wataya K. Familial neonatal transient hypothyroidism due to maternal TSH binding inhibitory immunoglobulins. N Engl J Med 1980; 303: 738-741.
29. Briet JM, van Wassenaer AG, Dekker FW, de Vijlder JJ, van Baar A, Kok JH. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001; 107: 712-718.
30. MacGillivray MH. Congenital hypothyroidism. In: Pescowitz OH, Eugster EA, eds. Pediatric Endocrinology. Philadelphia, PA: Lippincott Williams Wilkins, 2004; 490-507.
31. Hulse JA. Outcome for congenital hypothyroidism. Arch Dis Child 1984; 59: 23-30.
32. de Zegher F, Van der Bershe G, Dumolin M, Gewillig M, Daenen W, Devlieger H. Dopamine suppresses thyroid stimulating hormone secretion in neonatal hypothyroidism. Acta Paediatr 1995; 84: 213-214.
33. Spady DW, Saunders LD, Bamforth F. Who gets missed: coverage in a provincial newborn screening program for metabolic disease. Pediatrics 1998; 102: e21.
34. Van Vliet G. Thyroid disorders in infancy. In: Lifshitz F, ed. Pediatric Endocrinology. NewYork: Marcel Dekker Inc., 2003; 347-358.
35. LaFranchi S. Congenital hypothyroidism: etiologies, diagnosis and management. Thyroid 1999; 9: 738-740.
36. Van Tijn DA, de Vijlder JJM, Verbeeten B, Verkerk PH, Vulsma T. Neonatal detection of congenital hypothyroidism of central origin. J Clin Endocrinol Metab 2005; 90: 3350-3359.
37. Miki K, Nose O, Miyai K, Yabuuchi H, Harada T. Transient infantile hyperthyrotropinemia. Arch Dis Child 1989; 64: 1177-1182.
38. Klein RZ, Mitchell ML. Neonatal screening. In: Braverman LE, Utiger RD, eds. The Thyroid. Philadelphia, PA: Lippincott Williams Wilkins, 2000; 973-977.
39. Yang RL, Zhu ZW, Zhou XL, Zhao ZY. Treatment and followup of children with transient congenital hypothyroidism. J Zhejiang Univ Sci B 2005; 6: 1206-1209.
40. Höpfner S, Höpfner B, Rauterberg EW. Neonatal screening for congenital hypothyroidism in Hessen, Germany: efficiency of the screening program and school achievement of 129 children at an age of 8-12 years. J Perinat Med 2005; 33: 543-548.
41. Selva K, Harper A, Downs A, Blasco PA, LaFranchi SH. Neurodevelopmental outcomes in congenital hypothyroidism: comparision of initial T4 dose and time to reach target T4 and TSH. J Pediatr 2005; 147: 775-780.
42. Song SI, Daneman D, Rovet J. The influence of etiology and treatment factors on intellectual outcome in congenital hypothyroidism. J Dev Behav Pediatr 2001; 22: 376-384.
43. Vogiatzi MG, Kirkland JL. Frequency and necessity of thyroid function tests in neonates and infants with congenital hypothyroidism. Pediatrics 1997; 100: e6.
44. American Academy of Pediatrics. Newborn screening for congenital hypothyroidism: recommended guidelines. Pediatrics 1993; 91: 1203-1209.
45. Darcan S, Gokcen D. Consequences of iodine deficiency and preventive measures. Pediatr Endocrinol Rev 2003; 1 (Suppl 2): 167-169.
46. Hetzel BS. Iodine and neuropsychological development. J Nutr 2000; 130: 493S-495S.
47. Boyages SC. Iodine deficiency disorders. J Clin Endocrinol Metab 1993; 77: 587-591.
48. Delong R. Neurological involvement in iodine deficiency disorders. In: Hetzel BS, Dunn JT, Stanbury JB, eds. The Prevention and Control of Iodine Deficiency Disorders. Amsterdam: Elsevier, 1987; 49-63.
49. WHO. Trace Elements in Human Nutrition and Health. Geneva: WHO, 1996; 49-62.
50. Galanti MR, Sparen P, Karlsson A, Grimelius L, Ekbom A. Is residence in areas of endemic goiter a risk factor for thyroid cancer? Int J Cancer 1995; 61: 615-621.
51. Shi YF, Zou MJ, Schmidt H, Juhasz F, Stensky V, Robb D, Farid NR. High rates of RAS codon 61 mutation in thyroid tumors in an iodine deficient area. Cancer Res 1991; 51: 2690-2693.
52. Soldin OP. Controversies in urinary iodine determinations. Clin Biochem 2002; 35: 575-579.
53. Spencer JA. Laboratory medicine practice guidelines. Urinary iodine measurement. Thyroid 2003; 3: 75-79.
54. Mantel M. Improved method for the determination of iodine in urine. Clin Chim Acta 1971; 33: 39-44.
55. Tsuda K, Namba H, Nomura T, Yokoyama N, Yamashita S, Izumi M, Nagataki S. Automated measurement of urinary iodine with use of ultraviolet irridation. Clin Chem 1995; 41: 581-585.
56. Unak P, Darcan S, Yurt F, Biber Z, Coker M. Determination of iodide amounts in urine and water by isotype dilution analysis. Biol Trace Elem Res 1999; 71: 463-470.
57. WHO. Prevalence of IDD in school aged children based on urinary iodine. Iodine deficiency prevalence. 2003. http:/who.int/whosis/mn/mn-iodine/ mn-prevalence
58. Li M, Eastman CJ, Waite KV, Ma G, Zacharin MR, Topliss DJ, Harding PE, Walsh JP, Ward LC, Mortimer RH, Mackenzie EJ, Byth K, Doyle Z. Are Australian children iodine deficient? Results of the Australian National Iodine Study. Med J Aust 2006; 184: 165-169.
59. DeLange F, Hetzel B. The iodine deficiency disorders. http://www.thyroidmanager.org/Chapter20/20-text.htm
60. Delange F. Iodine deficiency in Europe and its consequences: an update. Eur J Nucl Med Mol Imaging 2002; 29: 404-416.
61. WHO Report by the Secretariat. Iodine deficiency. Executive Board 103rd Session provisional 12 Nov 1998.
62. WHO-UNICEF-ICCIDD. Indicators for assessing iodine deficiency disorders and their control through salt iodization. WHO/NUT/94.6. Geneva: WHO, 1994.
63. Buttfield IH, Hetzel BS. Endemic goiter in eastern New Guinea, with special reference to the use of iodized oil in prophylaxis and treatment. Bull WHO 1967; 36: 243-262.
64. Clements FW. Goiter prophylaxis by addition of potassium iodate to bread. Experience in Tasmania. Lancet 1970; i: 489-492.
65. Foo LC, Zainab T, Goh SY, Letchuman GR, Nafikudin M, Doraisingam P, Khalid B. Iodization of village water supply in the control of endemic iodine deficiency in rural Sarawak, Malaysia. Biomed Environ Sci 1996; 9: 236-241.